TherapeuticsMD (TXMD) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free TXMD Stock Alerts $1.92 +0.04 (+2.13%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 25 at 2:52 AMTherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.comamericanbankingnews.com - April 19 at 2:14 AMTherapeuticsMD Announces Full Year 2023 Financial Resultsbusinesswire.com - March 29 at 4:00 PM25 Countries With Highest Abortion Ratesmsn.com - March 12 at 3:55 PMTherapeuticsMD, Inc. (TXMD) stock historical prices & data – Yahoo Financesg.finance.yahoo.com - March 10 at 1:13 PMTherapeuticsMD Inc TXMDmorningstar.com - December 29 at 5:48 PMDaily Markets: Today Brings Producer Prices, Retail Sales Datanasdaq.com - November 15 at 9:54 AMTherapeuticsMD to Consider Strategic Alternativesmarketwatch.com - November 14 at 7:04 PMTherapeuticsMD exploring strategic alternatives for companymsn.com - November 14 at 6:27 PMTherapeuticsMD Announces Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 6:27 PMBoca Raton-based prescription service announces layoffs, says a third of workforce could be cutbizjournals.com - October 4 at 5:11 PMTherapeuticsMD Inc. stock falls Wednesday, underperforms marketmarketwatch.com - September 20 at 6:46 PMTherapeuticsMD Inc. stock outperforms market despite losses on the daymarketwatch.com - August 15 at 7:00 PMTherapeuticsMD Announces Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 7:50 AMMicron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directorsfinance.yahoo.com - August 9 at 8:38 PMTherapeuticsMD Inc. stock underperforms Wednesday when compared to competitorsmarketwatch.com - July 5 at 6:51 PMTherapeuticsMD Rejected by FDA, Delay Could Be Fatalthestreet.com - July 4 at 7:28 AMTherapeuticsMD: From Fallen And Forgotten To Cash Cowseekingalpha.com - May 23 at 9:28 AMTherapeuticsMD Announces First Quarter 2023 Financial Resultsfinance.yahoo.com - May 15 at 4:19 PMTherapeuticsMD Inc. stock falls Tuesday, underperforms marketmarketwatch.com - May 10 at 8:44 PMTherapeuticsMD Inc. stock rises Wednesday, still underperforms marketmarketwatch.com - May 10 at 8:44 PMTherapeuticsMD Inc. stock falls Monday, underperforms marketmarketwatch.com - May 3 at 7:08 AMTherapeuticsMD Inc. stock underperforms Friday when compared to competitorsmarketwatch.com - April 30 at 10:17 AMTherapeuticsMD Inc. stock outperforms market on strong trading daymarketwatch.com - April 23 at 7:27 AMAll You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buymsn.com - April 14 at 1:44 PMTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transitionfinance.yahoo.com - April 7 at 5:01 PMTherapeuticsMD Inc. stock underperforms Monday when compared to competitorsmarketwatch.com - March 13 at 6:29 PMTheraputicsMD sells products rights for $153 millionbizjournals.com - January 5 at 10:00 AMTherapeuticsMD Completes Transaction to License Its Products to Mayne Pharmafinance.yahoo.com - January 3 at 7:13 AMTXMD.A - TherapeuticsMD Inc | Stock Price & Latest News | Reutersreuters.com - December 26 at 8:32 AMTechnology & Innovation Roundup: Company will cut 212 employees after failed buyoutbizjournals.com - December 19 at 7:47 AMTherapeuticsMD Inc. stock falls Thursday, underperforms marketmarketwatch.com - December 16 at 2:22 PMTherapeuticsMD Inc. stock rises Wednesday, outperforms marketmarketwatch.com - December 15 at 5:42 AMTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharmafinance.yahoo.com - December 4 at 9:54 PMTherapeuticsMD Announces Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 15 at 5:31 AMTherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - November 15 at 5:31 AMTherapeuticsMD, Inc. (TXMD) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - November 13 at 3:56 PMTherapeuticsMD Announces Additional $7 Million Private Placementfinance.yahoo.com - October 31 at 10:34 AMTherapeuticsMD receives $7M investment after merger plans unravel - South Florida Business Journal - The Business Journalsbizjournals.com - October 3 at 5:24 PMTherapeuticsMD receives $7M investment after merger plans unravelfinance.yahoo.com - October 3 at 5:24 PMTherapeuticsMD rannounces $7 million private placement - Seeking Alphaseekingalpha.com - October 3 at 12:23 PMTHERAPEUTICSMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - October 3 at 7:23 AMTherapeuticsMD Announces $7 Million Private Placement - Business Wirebusinesswire.com - October 3 at 7:23 AMTherapeuticsMD Announces $7 Million Private Placementfinance.yahoo.com - October 3 at 7:23 AMTherapeuticsMD Inc. stock outperforms market despite losses on the day - MarketWatchmarketwatch.com - September 30 at 9:28 PMTherapeuticsMD (TXMD) Stock Surges on Successful Vaginal Atrophy Drug Trialthestreet.com - September 17 at 6:29 PMPrenatal Vitamin Supplements Market to record USD 230.86 Mn growth -- Driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers - Yahoo Financefinance.yahoo.com - September 16 at 5:32 AMTherapeuticsMD Appoints Brian Bernick, Mark Glickman as Interim Co-CEOs - Marketscreener.commarketscreener.com - September 12 at 4:59 PMTherapeuticsMD CEO O'Dowd Steps Down After Less Than a Year - MarketWatchmarketwatch.com - September 12 at 9:03 AMTherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers - Yahoo Financefinance.yahoo.com - September 12 at 9:03 AM Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… TXMD Media Mentions By Week TXMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXMD News Sentiment▼0.360.44▲Average Medical News Sentiment TXMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXMD Articles This Week▼20▲TXMD Articles Average Week Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cumberland Pharmaceuticals News Cardio Diagnostics News Biora Therapeutics News Nephros News DermTech News NeuroSense Therapeutics News MEI Pharma News OncoCyte News Evaxion Biotech A/S News PolyPid News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXMD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
